Physician’s Profile

Michael D. Kluger, MD, MPH

Medical Director, Milstein Hospital 6HS Surgical Oncology Unit
Contact Phone: 
(212) 305-6514
Board Certificates: 
Pancreatic Cancer
Liver Cancer
Hepatobiliary Surgery
Cancer Care
Pancreatic Surgery
Liver Surgery
Hepato-Biliary Surgery
Gallbladder Surgery
Neuroendocrine Tumor
Gallbladder Cancer
Bile Duct Injury
Metastatic Cancer to Liver
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Mesothelioma of Peritoneum
New York Presbyterian Hospital Physician of the Year, 2016
Society of Surgery of the Alimentary Tract, Hepatobiliary Sub-Committee, 2015
Super Doctors Rising Stars, 2015 & 2016
Teaching & Mentor Award, Department of Surgery, Columbia University, 2015
The Kenneth A. Forde Research Award, 2014
Excellence in Teaching Award, Weill Cornell Medical College, 2013
Presidential Poster of Distinction, American Association for the Study of Liver Diseases, 2011
European Society of Organ Transplantation Short Stay and Travel Grant, 2009
Philippe Foundation Award for Franco-American Scientific Collaboration, 2009
Humanism and Excellence in Teaching Award, Arnold P. Gold Foundation, 2007
Alpha Omega Alpha Medical Honor Society, 2004
Arthur Zitrin Award in Bioethics, 2004
New York Medical Society Community Service Award, 2004
Psi Chi National Psychology Honor Society, 1998

A pilot study to determine the safety of recovered blood intended for auto-transfusion during pancreatic cancer operations.  National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000040).

The roles of tumor-penetrating iRGD peptide in Hyperthermic Intraperitoneal Chemotherapy (HIPEC).  Columbia University Department of Surgery Startup Grant

Pancreatic Canceer
Colorectal Metastases to the Liver and Peritoneum
Surgical Safety
Blood Transfusion During Surgery

Dr. Michael Kluger is board-certified in general surgery and specialty trained in liver and pancreas surgery. He focuses on the operative management of pancreatic cancer, liver cancer, gallbladder disease and metastases to the liver and abdominal peritoneum. These complex diseases require treatment plans tailored to each patient's needs; therefore Dr. Kluger employs a multidisciplinary approach to determine the best available treatment options that maximize survival and quality of life. He is highly skilled in minimally invasive procedures, and uses laparoscopy whenever indicated.

Dr. Kluger graduated from the New York University School of Medicine, where he was elected to the Alpha Omega Alpha medical honor society and received awards for bioethics and community service. He completed his surgical residency at NewYork-Presbyterian Hospital/Columbia University Medical Center. There he was selected to be the Administrative Chief Resident and won the Gold Foundation Humanism and Excellence in Teaching Award. He received advanced training in liver transplantation and hepatobiliary surgery at Hospital Henri Mondor in France under the world-renowned surgeon Professor Daniel Cherqui. He is a Fellow of the American College of Surgeons, and a member of several prestigious professional organizations, including the Society of Surgical Oncology and the Society for Surgery of the Alimentary Tract.

Peer reviewed publications -  Yeh R, Steinman J, Luk L, Kluger MD, Hecht EM.  Imaging of pancreatic cancer: what the surgeon wants to know.  Clinical Imaging.  2016;7(42):203-217. PMID: 28110203. -  Leinwand JC, Chabot JA, Kluger MD.  Preventing recurrence of diffuse malignant peritoneal mesothelioma.  Expert Review of Anticancer Therapy. 2016;16(9):989-95. PMID: 27486718 -  Parekh M, Kluger MD, Griesemer A, Bentley-Hibbert S.  Regenerative liver surgeries: the alphabet soup of emerging techniques.  Abdominal Radiology. 2016;41(1):162-73.  PMID: 26830622   -  Kluger MD, Epelboym I, Schrope BA, et al. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients. Ann Surg Oncol. 2015 Dec 29. -  Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. Accepted for Publication 7/7/2015: HPB. PMID: 26